Authors:
Shapiro, GS
Klinger, NM
Ekholm, BP
Colice, GL
Citation: Gs. Shapiro et al., Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol andchlorofluorocarbons-11/12 (CFC) albuterol in children with asthma, J ASTHMA, 37(8), 2000, pp. 667-675
Authors:
Parameswaran, KN
Inman, MD
Ekholm, BP
Morris, MM
Summers, E
O'Byrne, PM
Hargreave, FE
Citation: Kn. Parameswaran et al., Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta(2)-agonist, AM J R CRIT, 160(1), 1999, pp. 354-357
Authors:
Bronsky, E
Ekholm, BP
Klinger, NM
Colice, GL
Citation: E. Bronsky et al., Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol, J ASTHMA, 36(1), 1999, pp. 107-114
Authors:
Harrison, LI
Soria, I
Cline, AC
Ekholm, BP
Citation: Li. Harrison et al., Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics, J PHARM PHA, 51(11), 1999, pp. 1235-1240
Authors:
Ramsdell, JW
Colice, GL
Ekholm, BP
Klinger, NM
Citation: Jw. Ramsdell et al., Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma, ANN ALLER A, 81(6), 1998, pp. 593-599